Rosalyn Juergens, MD, PhD | Authors


A Study of Chemotherapy With Durvalumab and Tremelimumab in NSCLC

February 09, 2017

Rosalyn Juergens, MD, PhD, assistant professor, Department of Oncology, Division of Medical Oncology, McMaster University, discusses a clinical trial investigating chemotherapy with durvalumab and tremelimumab in patients with non-small cell lung cancer (NSCLC).